Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 633-639

  Liang, Dong ^a   Shi, YuZhi ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Acetaldehyde dehydrogenase 1; Cancer stem cell; Lung adenocarcinoma

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; TUMOR MARKER; UNCLASSIFIED DRUG; ISOENZYME; RETINAL DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CELL CLONE; CELL COUNT; CELL PROLIFERATION; CELL SELECTION; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LATENT PERIOD; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; SPHEROID CELL; ADENOCARCINOMA; ANIMAL; CELL TRANSFORMATION; DRUG SCREENING; ENZYMOLOGY; LUNG TUMOR; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY;

ADENOCARCINOMA; ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CULTURE MEDIA, SERUM-FREE; FLOW CYTOMETRY; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; PHENOTYPE; RETINAL DEHYDROGENASE; SPHEROIDS, CELLULAR; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY;

EID: 84866280174     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9933-9     Document Type: Article

References (22)

1. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-11.
2. Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645-8.
3. Bonnet D, Dick JE, et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730-7.
4. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396-401.
5. Singh SK, Clarke ID, Hide T, et al. Cancer stem cells in nervous system tumors. Oncogene. 2004;23:7267-73.
6. Al-Hajj M, Wicha MS, Benito-Hemandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983-8.
7. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65: 10946-51.
8. Suetsugu A, Nagaki M, Aoki H, et al. Characterization of CD133 + hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun. 2006;351:820-4.
9. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106-10.
10. Prince ME, Sivanandan R, Kaczorowski A. et al.: Identification of a subpopulation of cells witll cancer stem cell properties in head and neck squarnous cell carcinoma. Proc Natl Acad Sci USA. 2007;104:973-8.
11. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH-1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. J Cell Stem Cell. 2007;12: 555-67.
12. Ling Z, Pei Y, Jianfeng W, et al. Expression of aldehyde dehydrogenase 1 in breast cancer and its clinical significance. Tumor. 2009;29:663-7.
13. Giangreco A, Groot KR, Janes SM, et al. Lung cancer and lung stem cells: strange bedfellows? J Am J Respir Crit Care Med. 2006;175:547-53.
14. Mimeault M, Hauke R, Mehta PP, et al. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med. 2007;11:981-1011.
15. Russo JE, Hilton J, et al. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res. 1988;48:2963-8.
16. Labrecque J, Bhat PV, Lacroix A, et al. Purification and partial characterization of a rat kidney aldehyde dehydrogenase that oxidizes retinal to retinoic acid. Biochem Cell Biol. 1993;71: 85-9.
17. Storms RW, Trujillo AP, Springer JB, et al. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA. 1999;96: 9118-23.
18. Hess DA, Meyerrosse TE, Wirthlin L, et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 2004;104:1648-55.
19. Corti S, Locatelli F, Papadimitriou D, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells. 2006;24:975-85.
20. Balickid D, et al. Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1. J Cell Stem Cell. 2007;1:485-7.
21. Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase-1 is a tumor stem cell-associated marker in lung cance. J Mol Cancer Res. 2008;101:330-8.
22. Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15:504-14.